Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CDK9: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | CDK9 |
| Aliases | Cyclin-Dependent Kinase 9 |
| Protein Type | Serine/Threonine Kinase |
| Function | The CDK9 gene encodes Cyclin-Dependent Kinase 9, a 372-amino acid serine/threonine kinase |
| Primary Expression | neurons throughout the cortex, hippocampus, and basal ganglia |
| Subcellular Localization | s. CDK9 activity is regulated by cellular stress, growth factors, and signaling pathways |
| Molecular Weight | 43 kDa |
| Amino Acids | 372 aa |
| Ensembl ID | ENSG00000136807 |
| GeneCards | CDK9 |
| Human Protein Atlas | CDK9 |
| Transcriptional Elongation | Catalytic subunit of P-TEFb; phosphorylates RNA Pol II CTD Ser2, NELF, and DSIF to enable transcription elongation[@zhou2013]. |
| Gene Expression Control | Regulates expression of immediate-early genes, heat shock proteins, and anti-apoptotic genes. |
| Neuronal Survival | Protects neurons from oxidative stress and excitotoxicity through regulation of neurotrophic factor expression. |
| Mitochondrial Function | Regulates expression of mitochondrial genes and proteins involved in energy metabolism. |
| Associated Diseases | neurodegeneration |
| Interactions | AND, APOPTOSIS, BRD4, DNA, DYRK1A, Fus |
| KG Connections | 40 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
CDK9["CDK9"]
Als{"Als"}
CDK9 -->|"activates"| Als
CDK9 -->|"regulates"| Als
ALS{"ALS"}
CDK9 -->|"activates"| ALS
DNA["DNA"]
CDK9 -->|"activates"| DNA
TBX3["TBX3"]
CDK9 -->|"regulates"| TBX3
TCF3["TCF3"]
CDK9 -->|"regulates"| TCF3
AND["AND"]
CDK9 -->|"activates"| AND
neurodegeneration["neurodegeneration"]
CDK9 -->|"implicated in"| neurodegeneration
MYC["MYC"]
MYC -->|"regulates"| CDK9
DNA -->|"activates"| CDK9
style CDK9 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| POLR2A | interacts_with | gene | 0.85 |
| DNA damage response | mediates | process | 0.80 |
| CTD_phosphorylation | regulates | process | 0.70 |
| POLR2A_CTD_phosphorylation | regulates | process | 0.70 |
| ALS | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Lymphoma | inhibits | disease | 0.65 |
| Ras | phosphorylates | protein | 0.60 |
| Fus | inhibits | protein | 0.60 |
| RNA | inhibits | gene | 0.60 |
| Ras | activates | protein | 0.60 |
| GAIN | inhibits | gene | 0.60 |
| DYRK1A | inhibits | gene | 0.60 |
| SF3B1 | inhibits | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| DNA | associated_with | gene | 0.60 |
| RNA | associated_with | gene | 0.60 |
| Apoptosis | inhibits | pathway | 0.60 |
| DNA | phosphorylates | gene | 0.60 |
| RNA | phosphorylates | gene | 0.60 |
| AND | phosphorylates | gene | 0.60 |
| GENES | inhibits | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| YTHDF2 | regulates | gene | 0.60 |
| B Cell | inhibits | cell_type | 0.60 |
| TBX3 | regulates | gene | 0.60 |
| TCF3 | regulates | gene | 0.60 |
| B Cell | expressed_in | cell_type | 0.55 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-08 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning CDK9 in their description or question text
No additional research found